Key Trends Influencing the Growth of the Tuberculosis Diagnostics Market in 2025: Tech Advancements Transforming Tuberculosis Diagnostics Market

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Tuberculosis Diagnostics Market Size By 2025?
There has been a significant expansion in the tuberculosis diagnostics market size in the preceding years. It is projected to increase from $2.21 billion in 2024 to about $2.36 billion in 2025, maintaining a CAGR of 6.9%. The historical growth of this market can be linked to factors such as the escalating cases of tuberculosis, amplified healthcare spending, the growing number of healthcare facilities, and an upsurge in the employment of nucleic acid testing.

How Big Is the Tuberculosis Diagnostics Market Size Expected to Grow by 2029?
The size of the tuberculosis diagnostics market is anticipated to solidly increase in the years ahead. A compound annual growth rate (CAGR) of 8.2% is projected to raise it to $3.24 billion by 2029. This conceivable expansion during the predicted period is due to impactful factors such as robust government backing, escalating FDA endorsements for tuberculosis diagnostics, amplified research and development undertakings, and the surfacing of drug-resistant TB. The prospective period is set to observe significant trends like the concentration on next-generation sequencing (NGS) platforms for TB diagnosis, advancements in product, t-cell assessments for TB infection, TB diagnostics informed by artificial intelligence (AI), the employment of lightweight devices, and partnerships formed between governments and manufacturers.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Which Key Market Drivers Powering Tuberculosis Diagnostics Market Expansion and Growth?
The escalating occurrence of tuberculosis is fuelling the demand for tuberculosis diagnostics in the market. Tuberculosis is a severe infectious disease predominantly affecting the lungs and spreads by dispersing minuscule bacteria into the air via coughing and sneezing. Tuberculosis diagnostics plays a crucial role in identifying patients with the disease at an early stage, thereby detecting the disease faster. For example, in March 2023, the Centers for Disease Control and Prevention, a public health organization in the US, reported 8,300 cases of tuberculosis in the United States in 2022, an increase from 7,874 cases in 2021. Consequently, this surge in tuberculosis incidence is propelling the demand in the tuberculosis diagnostics market. Thus, the growth of the tuberculosis diagnostics market is propelled by the escalating number of tuberculosis cases.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Tuberculosis Diagnostics Market?
The increasing popularity of technological advancements has become a significant trend in the tuberculosis diagnostics market. Many prominent companies in the industry are turning to innovative technologies, such as sophisticated point-of-care (POC) diagnostic tools that utilize AI technology, to maintain their market standing. As an example, in August 2022, Fujifilm, a Japanese company specializing in the production of medical imaging equipment, joined forces with Qure.ai, a US-based company that develops AI-powered medical imaging solutions. This collaboration resulted in the launch of a cutting-edge point-of-care (POC) diagnostic procedure. This method employs a battery-powered X-ray machine for TB diagnosis, using artificial intelligence algorithms to facilitate effective testing programs and provide highly portable, exceptionally accurate, and efficient point-of-care diagnostic results.

What Are the Emerging Segments in the Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market covered in this report is segmented -

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Who Are the Global Leaders in the Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Which are the Top Profitable Regional Markets for the Tuberculosis Diagnostics Industry?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe - +44 7882 955267
Asia: +91 88972 63534
Americas - +1 310-496-7795
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.